Posts

Showing posts from July, 2026

Export Opportunities for Gynae and Infertility Medicines from India

India has a reputed,  affordable, quality-conscious pharma manufacturer. The Export interest in the gynae and infertility category specifically has picked up over the last few years. Countries across Africa, Southeast Asia, and the CIS region are seeing rising rates of infertility diagnosis alongside a growing willingness among patients to actually pursue treatment instead of ignoring it. Local supply in many of these regions is not enough to fulfil the demand, and Indian exporters of gynae and infertility medicines have stepped in to fill the gap. Why Are Buyers Looking Toward India? Indian manufacturers combine competitive pricing with certifications that are recognised internationally, which gives overseas distributors and hospitals a level of confidence. On top of that, the sheer range of formulations available from Indian suppliers is a real advantage.  Buyers looking for progesterone support, ovulation induction medicines, folic acid and prenatal combinations, or hormona...

Why Third-Party Manufacturing Is Reshaping the Gynaecology Pharma Industry?

Gynaecology and infertility care is consistently growing segment in the India's pharma industry. More couples are seeking fertility treatment, women's reproductive health is finally getting the attention it deserves in both cities and smaller towns, and doctors are prescribing a far wider mix of hormonal and supportive therapies than they were prescribing even five years back. Demand is constantly rising for the infertility and gynecology products. There is a big gap in the demand and supply. But this gap can be filled by the third-party manufacturing for gynae and infertility medicines. The Shift From Building to Partnering The old approach meant a company invest crores into its own plant, hiring a full production team, and waiting years before a single batch was ready to ship. Very few businesses can afford that kind of runway anymore. Third-party manufacturing flips the model a company partners with an already-established, WHO-GMP certified facility and gets its formulations...